• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic indicators in renal adenocarcinoma.

作者信息

Siminovitch J M, Montie J E, Straffon R A

出版信息

J Urol. 1983 Jul;130(1):20-3. doi: 10.1016/s0022-5347(17)50933-7.

DOI:10.1016/s0022-5347(17)50933-7
PMID:6864906
Abstract

From 1968 to 1978, 246 patients underwent surgical exploration for renal adenocarcinoma at our clinic. Of these patients 241 had complete tumor excision and 5 had biopsy only. Correlation of the clinical and pathological data of these patients with the clinical course identified prognostic parameters. Disease progression was uncommon when the tumor was contained within the capsule of the kidney (9 of 80 patients). Perinephric tumor extension indicated a worse prognosis (11 of 40 patients with progression) that was not altered significantly by the presence of renal vein involvement (17 of 35 patients with progression). Inferior vena caval involvement or regional lymph node metastases worsened the prognosis markedly, with 8 of 11 and 8 of 9 patients demonstrating progressive disease, respectively. The worst prognosis was seen in patients with metastatic disease at operation (66 of the 71 patients dying of the disease by the end of followup). The disease was classified according to the tumor, node and metastasis system of the American Joint Committee and a stage grouping system has been suggested.

摘要

相似文献

1
Prognostic indicators in renal adenocarcinoma.
J Urol. 1983 Jul;130(1):20-3. doi: 10.1016/s0022-5347(17)50933-7.
2
[Anatomical classification of adenocarcinomas of the kidney. Reflections apropos of 270 surgically treated cases].[肾腺癌的解剖学分类。关于270例手术治疗病例的思考]
J Urol (Paris). 1986;92(1):1-6.
3
Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma.肾静脉和腔静脉受累不影响肾细胞癌患者的预后。
Oncology. 2001;61(1):10-5. doi: 10.1159/000055346.
4
Prognostic factors for renal cell carcinoma with tumor thrombus extension.伴有肿瘤血栓延伸的肾细胞癌的预后因素
J Urol. 2007 Oct;178(4 Pt 1):1189-95; discussion 1195. doi: 10.1016/j.juro.2007.05.134. Epub 2007 Aug 14.
5
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.伴有下腔静脉侵犯的转移性肾细胞癌:根治性肾切除术、腔静脉血栓切除术及术后免疫治疗联合治疗后的长期生存情况
J Urol. 1999 Jul;162(1):46-50. doi: 10.1097/00005392-199907000-00012.
6
Prognostic implications of vena caval extension of renal cell carcinoma.
J Urol. 1982 Nov;128(5):910-2. doi: 10.1016/s0022-5347(17)53273-5.
7
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
8
Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium.肾细胞癌侵犯右心房手术治疗后的长期随访
J Urol. 1996 Feb;155(2):448-50.
9
[A critical study of the prognosis of renal adenocarcinoma and an attempted classification. Apropos of a series of 322 cases].[肾腺癌预后的批判性研究及分类尝试。基于322例病例系列]
Ann Urol (Paris). 1990;24(6):504-11.
10
Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.肿瘤血栓延伸至腔静脉的肾细胞癌:手术策略与预后
J Vasc Surg. 2001 Apr;33(4):789-96. doi: 10.1067/mva.2001.111996.

引用本文的文献

1
The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis.淋巴结清扫术在非转移性肾细胞癌中的作用:一项更新的系统评价和荟萃分析
Front Oncol. 2022 Jan 12;11:790381. doi: 10.3389/fonc.2021.790381. eCollection 2021.
2
Prognostic significance of perirenal infiltration in renal cell carcinoma (<7 cm).肾细胞癌(<7cm)肾周浸润的预后意义。
Yonsei Med J. 2012 Sep;53(5):940-3. doi: 10.3349/ymj.2012.53.5.940.
3
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
多药耐药蛋白(MDR-1)在肾透明细胞癌中的预后意义:一项五年随访分析。
BMC Cancer. 2006 Dec 19;6:293. doi: 10.1186/1471-2407-6-293.
4
[Renal cell carcinoma. Comparative analysis of the prognostic significance of the WHO-classification and the Störkel's prognostic score].[肾细胞癌。世界卫生组织分类与施托克尔预后评分预后意义的比较分析]
Urologe A. 2004 Apr;43(4):450-6. doi: 10.1007/s00120-004-0539-0.
5
Multivariate evaluation of prognostic determinants for renal cell carcinomas which are metastatic at initial diagnosis.
Int Urol Nephrol. 1997;29(3):291-300. doi: 10.1007/BF02550925.
6
Surgical treatment of renal cell carcinoma metastases: prognostic significance.肾细胞癌转移的外科治疗:预后意义
Int Urol Nephrol. 1995;27(1):1-8. doi: 10.1007/BF02575213.
7
Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.长春花碱、阿霉素及优福定用于肾细胞癌的辅助化疗。
Cancer Chemother Pharmacol. 1992;30(6):477-9. doi: 10.1007/BF00685600.